Skip to main content

Table 1 Patient characteristics and treatment plan

From: Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F]FDGal PET/CT

ID

Sex/age

Diagnosis

Number of tumors treated

Previous local treatment

Σ CTV (cc)

Liver-CTV (cc)

Total dose (Gy)/fractions

1

M/59

IHC

1

67.7

2829.0

54/6

2

M/62

mCRC

1

16.1

1775.8

56.25/3

3

M/68

mCRC

1

RFA

6.3

3219.9

56.25/3

4

F/91

mCRC

1

44.1

1121.9

45/3

5

M/64

mCRC

3

RFA

25.0

2113.7

45/3

6

M/62

mCRC

2

Resection

1.2

1433.3

56.25/3

  1. M male, F female, IHC intrahepatic cholangiocarcinoma, mCRC metastatic colorectal cancer, RFA radiofrequency ablation, Σ sum, CTV clinical target volume, cc cubic centimeters, Gy gray